Palisade Bio (PALI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.41, -8.44% vs the prior close of $1.54.
- Volume 3.89M shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PALI slides 8.4% to $1.41. Closed at $1.41, -8.44% vs the prior close of $1.54. Day range $1.40–$1.56, opened at $1.55.
PALI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PALI slides 8.4% to $1.41
- Closed at $1.41, -8.44% vs the prior close of $1.54. Day range $1.40–$1.56, opened at $1.55.
- Volume was 3.89M shares, 1.5x its 50-day average of 2.59M.
- Price is -22.5% vs its 50-day average ($1.82) and -25.4% vs its 200-day average ($1.89).
- 52-week range $1.32–$2.86; today's close sits at 6% of that range, 50.7% below the 52-week high.
Oct 15, 2026 — PALI jumps 4.1% to $1.54
- Closed at $1.54, +4.05% vs the prior close of $1.48. Day range $1.48–$1.56, opened at $1.50.
- Volume was 1.82M shares, 0.7x its 50-day average of 2.60M.
- Price is -15.9% vs its 50-day average ($1.83) and -18.7% vs its 200-day average ($1.89).
- 52-week range $1.32–$2.86; today's close sits at 14% of that range, 46.2% below the 52-week high.
Oct 14, 2026 — PALI rises 0.7% to $1.48
- Closed at $1.48, +0.68% vs the prior close of $1.47. Day range $1.38–$1.51, opened at $1.45.
- Volume was 4.16M shares, 1.6x its 50-day average of 2.55M.
- Price is -19.7% vs its 50-day average ($1.84) and -22.1% vs its 200-day average ($1.90).
- 52-week range $1.32–$2.86; today's close sits at 10% of that range, 48.3% below the 52-week high.
Oct 13, 2026 — PALI slides 7.5% to $1.47
- Closed at $1.47, -7.55% vs the prior close of $1.59. Day range $1.46–$1.58, opened at $1.56.
- Volume was 1.59M shares, 0.6x its 50-day average of 2.53M.
- Price is -20.8% vs its 50-day average ($1.86) and -22.7% vs its 200-day average ($1.90).
- 52-week range $1.32–$2.86; today's close sits at 10% of that range, 48.6% below the 52-week high.
Oct 12, 2026 — PALI jumps 3.2% to $1.59
- Closed at $1.59, +3.25% vs the prior close of $1.54. Day range $1.51–$1.63, opened at $1.53.
- Volume was 1.57M shares, 0.6x its 50-day average of 2.54M.
- Price is -14.7% vs its 50-day average ($1.86) and -16.6% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 18% of that range, 44.4% below the 52-week high.
Oct 9, 2026 — PALI jumps 6.2% to $1.54
- Closed at $1.54, +6.21% vs the prior close of $1.45. Day range $1.47–$1.57, opened at $1.49.
- Volume was 1.84M shares, 0.7x its 50-day average of 2.52M.
- Price is -17.7% vs its 50-day average ($1.87) and -19.3% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 14% of that range, 46.2% below the 52-week high.
Oct 8, 2026 — PALI dips 2.0% to $1.45
- Closed at $1.45, -2.03% vs the prior close of $1.48. Day range $1.38–$1.48, opened at $1.47.
- Volume was 2.08M shares, 0.8x its 50-day average of 2.51M.
- Price is -22.8% vs its 50-day average ($1.88) and -24.1% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 8% of that range, 49.3% below the 52-week high.
Oct 7, 2026 — PALI dips 0.7% to $1.48
- Closed at $1.48, -0.67% vs the prior close of $1.49. Day range $1.44–$1.48, opened at $1.46.
- Volume was 825.20K shares, 0.3x its 50-day average of 2.54M — lighter than usual.
- Price is -21.7% vs its 50-day average ($1.89) and -22.6% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 10% of that range, 48.3% below the 52-week high.
Oct 6, 2026 — PALI rises 2.1% to $1.49, 4 up days in a row
- Closed at $1.49, +2.05% vs the prior close of $1.46. Day range $1.47–$1.55, opened at $1.51.
- Volume was 1.97M shares, 0.8x its 50-day average of 2.53M.
- Price is -21.6% vs its 50-day average ($1.90) and -22.2% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 11% of that range, 47.9% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — PALI rises 1.4% to $1.46, 3 up days in a row
- Closed at $1.46, +1.39% vs the prior close of $1.44. Day range $1.41–$1.48, opened at $1.44.
- Volume was 1.60M shares, 0.6x its 50-day average of 2.54M.
- Price is -23.6% vs its 50-day average ($1.91) and -23.8% vs its 200-day average ($1.91).
- 52-week range $1.32–$2.86; today's close sits at 9% of that range, 49.0% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — PALI rises 0.7% to $1.44
- Closed at $1.44, +0.70% vs the prior close of $1.43. Day range $1.43–$1.48, opened at $1.46.
- Volume was 1.99M shares, 0.8x its 50-day average of 2.62M.
- Price is -25.0% vs its 50-day average ($1.92) and -24.9% vs its 200-day average ($1.92).
- 52-week range $1.32–$2.86; today's close sits at 8% of that range, 49.7% below the 52-week high.
PALI latest news & SEC filings
Every SEC filing by or about PALI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jones Mitchell Lawrence converted options/RSUs into 2,620,850 shares on Oct 6, 2026; now holds 2,714,859
- Jones Mitchell Lawrence had withheld for taxes 1,031,102 shares at $1.49 (≈$1.54M) on Oct 6, 2026; now holds 1,683,757
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Finley John David converted options/RSUs into 3,227,384 shares on Oct 6, 2026; now holds 3,356,672
- Finley John David had withheld for taxes 1,411,982 shares at $1.49 (≈$2.10M) on Oct 6, 2026; now holds 1,944,690
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Williams Donald Allen bought 10,000 shares at $1.42 (≈$14.20K) on Oct 1, 2026; now holds 1,580,294
- Williams Donald Allen bought 10,000 shares at $1.46 (≈$14.60K) on Oct 2, 2026; now holds 1,590,294
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $500.00K (prior year $0)
- Net income: -$10.57M (prior year -$2.78M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.58) (loss narrowed vs Jun 30, 2025)
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baltera Robert Jr. bought 25,000 shares at $1.96 (≈$49.00K) on Jul 9, 2026
- Baltera Robert Jr. bought 25,000 shares at $1.96 (≈$49.00K) on Jul 9, 2026
- Baltera Robert Jr. bought 25,000 shares at $1.96 (≈$49.00K) on Jul 9, 2026
- Baltera Robert Jr. bought 25,000 shares at $1.96 (≈$49.00K) on Jul 9, 2026
- Baltera Robert Jr. bought 20,000 shares at $1.99 (≈$39.80K) on Jul 8, 2026
- Baltera Robert Jr. bought 20,000 shares at $1.99 (≈$39.80K) on Jul 8, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baltera Robert Jr. bought 30,000 shares at $2.03 (≈$60.90K) on Jul 7, 2026
- Baltera Robert Jr. bought 30,000 shares at $2.03 (≈$60.90K) on Jul 7, 2026
- Baltera Robert Jr. bought 30,000 shares at $2.03 (≈$60.90K) on Jul 7, 2026
- Baltera Robert Jr. bought 30,000 shares at $2.03 (≈$60.90K) on Jul 7, 2026
- Baltera Robert Jr. bought 20,000 shares at $2.05 (≈$41.00K) on Jul 6, 2026
- Baltera Robert Jr. bought 20,000 shares at $2.05 (≈$41.00K) on Jul 6, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade PALI
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 27, 2024, Mar 23, 2021. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.89% (largest 8.4%). That is a volatile stock.
- Liquidity: about 3.11M shares (≈$4.38M) trade per day on average.
- 52-week position: $1.41 vs a range of $1.32–$2.86 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Robert Jr. Baltera bought 25,000 shares on Jul 9, 2026.
- Latest filings: 8-K Aug 10, 2026; 10-Q Aug 10, 2026; 8-K Jun 11, 2026.
- Share count: 174.27M shares outstanding (Aug 6, 2026), +1811.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
PALI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.55 | 1.56 | 1.40 | 1.41 | 3.89M |
| Oct 15, 2026 | 1.50 | 1.56 | 1.48 | 1.54 | 1.82M |
| Oct 14, 2026 | 1.45 | 1.51 | 1.38 | 1.48 | 4.16M |
| Oct 13, 2026 | 1.56 | 1.58 | 1.46 | 1.47 | 1.59M |
| Oct 12, 2026 | 1.53 | 1.63 | 1.51 | 1.59 | 1.57M |
| Oct 9, 2026 | 1.49 | 1.57 | 1.47 | 1.54 | 1.84M |
| Oct 8, 2026 | 1.47 | 1.48 | 1.38 | 1.45 | 2.08M |
| Oct 7, 2026 | 1.46 | 1.48 | 1.44 | 1.48 | 825.20K |
| Oct 6, 2026 | 1.51 | 1.55 | 1.47 | 1.49 | 1.97M |
| Oct 5, 2026 | 1.44 | 1.48 | 1.41 | 1.46 | 1.60M |
| Oct 2, 2026 | 1.46 | 1.48 | 1.43 | 1.44 | 1.99M |
| Oct 1, 2026 | 1.39 | 1.46 | 1.37 | 1.43 | 2.64M |
| Sep 30, 2026 | 1.44 | 1.46 | 1.32 | 1.35 | 4.77M |
| Sep 29, 2026 | 1.54 | 1.55 | 1.42 | 1.45 | 2.16M |
| Sep 28, 2026 | 1.45 | 1.53 | 1.43 | 1.50 | 8.68M |
| Sep 25, 2026 | 1.57 | 1.59 | 1.45 | 1.45 | 5.78M |
| Sep 24, 2026 | 1.60 | 1.60 | 1.50 | 1.57 | 3.26M |
| Sep 23, 2026 | 1.69 | 1.70 | 1.59 | 1.60 | 2.94M |
| Sep 22, 2026 | 1.71 | 1.71 | 1.60 | 1.69 | 4.98M |
| Sep 21, 2026 | 1.64 | 1.69 | 1.60 | 1.69 | 3.57M |
About Palisade Bio
Palisade Bio (PALI) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in CARLSBAD, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1357459.
PALI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Jr. Baltera | Director | Jul 10, 2026 |
| Emil Chuang | Director | Jun 12, 2026 |
| John David Finley | CEO, CFO | Aug 21, 2026 |
| Binxian Wei | Director | Jun 12, 2026 |
| Donald Allen Williams | Director | Jun 12, 2026 |
| Jordan Michael Zwick | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John David Finley | CEO, CFO | Aug 21, 2026 |
| Mitchell Lawrence Jones | Chief Medical Officer | Jul 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 9, 2026 | Robert Jr. Baltera | Buy | 25,000 | $1.96 |
| Jul 9, 2026 | Robert Jr. Baltera | Buy | 25,000 | $1.96 |
| Jul 9, 2026 | Robert Jr. Baltera | Buy | 25,000 | $1.96 |
| Jul 9, 2026 | Robert Jr. Baltera | Buy | 25,000 | $1.96 |
| Jul 8, 2026 | Robert Jr. Baltera | Buy | 20,000 | $1.99 |
| Jul 8, 2026 | Robert Jr. Baltera | Buy | 20,000 | $1.99 |
| Jul 8, 2026 | Robert Jr. Baltera | Buy | 20,000 | $1.99 |
| Jul 8, 2026 | Robert Jr. Baltera | Buy | 20,000 | $1.99 |
| Jul 7, 2026 | Mitchell Lawrence Jones | Sale | 51,880 | $2.05 |
| Jul 7, 2026 | Mitchell Lawrence Jones | Sale | 51,880 | $2.05 |
| Jul 7, 2026 | Mitchell Lawrence Jones | Sale | 51,880 | $2.05 |
| Jul 7, 2026 | Mitchell Lawrence Jones | Sale | 51,880 | $2.05 |
| Jul 7, 2026 | Robert Jr. Baltera | Buy | 30,000 | $2.03 |
| Jul 7, 2026 | Robert Jr. Baltera | Buy | 30,000 | $2.03 |
| Jul 7, 2026 | Robert Jr. Baltera | Buy | 30,000 | $2.03 |
PALI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-16.78M | -0.30 | $-10.85M |
| Dec 31, 2024 | $0 | $-14.44M | -10.19 | $-12.19M |
| Dec 31, 2023 | $250.00K | $-12.30M | -27.01 | $-11.13M |
| Dec 31, 2022 | $0 | $-14.26M | -16.53 | $-13.36M |
| Dec 31, 2021 | — | $-26.62M | -169.74 | $-14.77M |
Latest balance sheet: total assets $127.31M, total liabilities $5.57M, cash $125.17M (as of Jun 30, 2026).
PALI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $2.10 |
| May 12, 2026 | 8-K Item 2.02 (results) | $1.92 |
| Mar 27, 2024 | 8-K Item 2.02 (results) | — |
| Mar 23, 2021 | 8-K Item 2.02 (results) | — |
| Nov 16, 2020 | 8-K Item 2.02 (results) | — |
| Aug 14, 2020 | 8-K Item 2.02 (results) | — |
| May 15, 2020 | 8-K Item 2.02 (results) | — |
| Apr 2, 2020 | 8-K Item 2.02 (results) | — |
| Nov 15, 2019 | 8-K Item 2.02 (results) | — |
| Aug 14, 2019 | 8-K Item 2.02 (results) | — |
| May 14, 2019 | 8-K Item 2.02 (results) | — |
| Mar 22, 2019 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PALI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.